| # | Drug | Count |
|---|---|---|
| 0 | OCTREOTIDE ACETATE | 310 |
| 1 | PEGVISOMANT | 135 |
| 2 | CABERGOLINE | 78 |
| 3 | METFORMIN | 68 |
| 4 | METFORMIN ER 500 MG | 62 |
| 5 | METFORMIN ER 750 MG | 62 |
| 6 | LEVOTHYROXINE SODIUM | 61 |
| 7 | HYDROCORTISONE | 53 |
| 8 | ATORVASTATIN CALCIUM | 45 |
| 9 | CANDESARTAN CILEXETIL | 43 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | PEGVISOMANT | 135 | 0.0329 |
| 1 | CABERGOLINE | 78 | 0.0158 |
| 2 | OCTREOTIDE ACETATE | 310 | 0.0101 |
| 3 | PASIREOTIDE | 13 | 0.0057 |
| 4 | LANREOTIDE ACETATE | 41 | 0.0052 |
| 5 | ACEBUTOLOL HYDROCHLORIDE | 4 | 0.0031 |
| 6 | BROMOCRIPTINE MESYLATE | 2 | 0.0031 |
| 7 | ESTRADIOL, FOLLICULINUM, OOPHORINUM (SUIS) | 4 | 0.0018 |
| 8 | CANDESARTAN CILEXETIL | 43 | 0.0016 |
| 9 | PRIMIDONE | 15 | 0.0015 |
| # | Drug class | Count |
|---|---|---|
| 0 | Ergot Derivative [EPC] | 78 |
| 1 | Corticosteroid [EPC] | 72 |
| 2 | Nonsteroidal Anti-inflammatory Drug [EPC] | 58 |
| 3 | Dihydropyridine Calcium Channel Blocker [EPC] | 50 |
| 4 | Platelet Aggregation Inhibitor [EPC] | 42 |
| 5 | Calcium Channel Blocker [EPC] | 40 |
| 6 | Benzodiazepine [EPC] | 39 |
| 7 | HMG-CoA Reductase Inhibitor [EPC] | 37 |
| 8 | Thiazide Diuretic [EPC] | 32 |
| 9 | Androgen [EPC] | 28 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Ergot Derivative [EPC] | 78 | 0.0158 |
| 1 | Somatostatin Analog [EPC] | 25 | 0.0036 |
| 2 | Androgen [EPC] | 28 | 0.0010 |
| 3 | Provitamin D2 Compound [EPC] | 27 | 0.0009 |
| 4 | Recombinant Human Growth Hormone [EPC] | 12 | 0.0005 |
| 5 | Serotonin Reuptake Inhibitor [EPC] | 17 | 0.0002 |
| 6 | Angiotensin Converting Enzyme Inhibitor [EPC] | 25 | 0.0002 |
| 7 | Insulin-like Growth Factor-1 Receptor Inhibitor [EPC] | 1 | 0.0002 |
| 8 | Pyrimidine Synthesis Inhibitor [EPC] | 7 | 0.0002 |
| 9 | Thiazide Diuretic [EPC] | 32 | 0.0002 |